Intego Clinical at PHUSE US Connect 2026, Advancing Innovation, Showcasing Expertise, and Celebrating Excellence
Intego Clinical was proud to participate in PHUSE US Connect 2026, held in Austin, Texas from March 22, 26. As one of the leading events in clinical data science, biometrics, and regulatory innovation, PHUSE continues to bring together experts from across the globe to share knowledge, explore emerging trends, and shape the future of clinical research.
This year, Intego Clinical had a strong presence at Booth 7, where our team connected with industry professionals, partners, and thought leaders. Representing our global footprint, colleagues from multiple regions came together to engage in meaningful conversations, exchange insights, and demonstrate how our expertise supports efficient, high-quality clinical trial delivery.
A key highlight of our participation was the opportunity to contribute to the conference through four impactful presentations:
Multiple Sclerosis Trials Unpacked: Standards, Endpoints and Programming Experience, presented by Daryna Teteriuk, this session explored the complexities of multiple sclerosis trials, focusing on standards implementation, endpoint considerations, and programming strategies.
The Journey Beyond Anonymization: Exploring the Secondary Use of Clinical Trial Data, Yuliia Cherednichenko and Tetiana Skorokhod examined the evolving landscape of clinical data reuse, addressing both opportunities and challenges in secondary data applications.
Coding Clinical R with Confidence: Digital AI Assistant based on Self-Hosted LLMs, Kostiantyn Drach and Iryna Kotenko presented innovative approaches to integrating AI-driven tools into statistical programming workflows, highlighting efficiency gains and practical applications.
From SAS to R for TLGs: A Case Study on Implementing a “R-first, SAS-QC” Workflow for Time-to-Event Analysis, Adler Moisés Rodríguez Fallas shared a real-world case study demonstrating the transition toward modern programming paradigms while maintaining robust quality control.
Among these contributions, we are especially proud to celebrate Daryna Teteriuk, who was awarded First Place in the “Data Standards” stream. This recognition reflects not only her individual excellence but also Intego Clinical’s commitment to advancing standards and delivering high-quality, submission-ready data.
PHUSE US Connect 2026 provided an invaluable platform to share knowledge, explore innovation, and strengthen relationships within the clinical research community. From engaging discussions at our booth to insightful sessions and networking opportunities, the event reinforced the importance of collaboration in advancing our industry.
At Intego Clinical, we remain committed to driving innovation in clinical data science, embracing new technologies, and delivering excellence in every project we undertake. Events like PHUSE allow us to not only showcase our capabilities but also learn, grow, and continue contributing to the evolution of clinical research.
We thank the PHUSE organization for hosting another exceptional event and look forward to continuing the conversations started in Austin. Interested in learning more about how Intego Clinical can support your clinical trials? Get in touch with our team, we’d love to connect.
